Literature DB >> 11405408

Use of tissue plasminogen activator in a stroke after radiofrequency ablation of a left-sided accessory pathway.

B C Cannon1, N J Kertesz, R A Friedman, A L Fenrich.   

Abstract

We describe the case of a 12-year-old girl who had a thromboembolic stroke after radiofrequency ablation of a left posterior accessory pathway involving a transseptal procedure. Symptoms of a stroke occurred 7 hours 15 minutes after completion of the procedure. Tissue plasminogen activator (tPA) was given 2 hours 30 minutes after the onset of symptoms, with complete resolution of her neurologic symptoms. No adverse effects from the tPA were seen. Because of the late onset of symptoms in this case, overnight in-hospital observation is warranted for patients who undergo radiofrequency ablation of a left-sided accessory pathway or an accessory pathway in a patient with the ability to shunt right to left. In this case, tPA was an effective and safe drug to use following a cerebral thromboembolic event occurring after a cardiac catheterization procedure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11405408     DOI: 10.1046/j.1540-8167.2001.00723.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  3 in total

1.  Potential eligibility for recombinant tissue plasminogen activator therapy in children: a population-based study.

Authors:  Laura L Lehman; Dawn O Kleindorfer; Jane C Khoury; Kathleen Alwell; Charles J Moomaw; Brett M Kissela; Pooja Khatri
Journal:  J Child Neurol       Date:  2011-05-31       Impact factor: 1.987

Review 2.  The roles of anatomic factors, thrombophilia, and antithrombotic therapies in childhood-onset arterial ischemic stroke.

Authors:  Timothy J Bernard; Marilyn J Manco-Johnson; Neil A Goldenberg
Journal:  Thromb Res       Date:  2010-10-13       Impact factor: 3.944

3.  Hyperacute therapies for childhood stroke: a case report and review of the literature.

Authors:  Jose Irazuzta; Kevin J Sullivan
Journal:  Neurol Res Int       Date:  2010-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.